| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHSURG.2007.15 |
| P698 | PubMed publication ID | 18209155 |
| P2093 | author name string | See Ching Chan | |
| Ronnie T P Poon | |||
| Chung Mau Lo | |||
| Chi Leung Liu | |||
| Sheung Tat Fan | |||
| Kelvin K Ng | |||
| P433 | issue | 1 | |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| recurrent hepatocellular carcinoma | Q19000463 | ||
| P304 | page(s) | 68-74; discussion 74 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | Archives of Surgery | Q15764793 |
| P1476 | title | Survival analysis of patients with transplantable recurrent hepatocellular carcinoma: implications for salvage liver transplant | |
| P478 | volume | 143 |
| Q92418088 | Comparison Between Salvage Liver Transplantation and Repeat Liver Resection for Recurrent Hepatocellular Carcinoma: A Systematic Review and Meta-analysis |
| Q47158857 | Comparison of repeated surgical resection and radiofrequency ablation for small recurrent hepatocellular carcinoma after primary resection |
| Q48243396 | Curative salvage liver transplantation in patients with cirrhosis and hepatocellular carcinoma: An intention-to-treat analysis |
| Q38692450 | Development of a Time-Resolved Fluorescence Immunoassay for the Diagnosis of Hepatocellular Carcinoma Based on the Detection of Glypican-3. |
| Q38374068 | Expression of OTUB1 in hepatocellular carcinoma and its effects on HCC cell migration and invasion |
| Q84310453 | Glypican-3, a novel prognostic marker of hepatocellular cancer, is related with postoperative metastasis and recurrence in hepatocellular cancer patients |
| Q84958635 | Hepatocellular carcinoma--resection or transplant? |
| Q43778834 | Impact of preoperative α-fetoprotein level on disease-free survival after liver transplantation for hepatocellular carcinoma. |
| Q90291739 | Inflammation-nutrition score predicts prognosis of patients with resectable hepatocellular carcinoma |
| Q82487021 | Intraoperative ultrasound score to predict recurrent hepatocellular carcinoma after radical treatments |
| Q92617277 | LncRNA GAS6-AS2 facilitates tumor growth and metastasis of hepatocellular carcinoma by activating the PI3K/AKT/FoxO3a signaling pathway |
| Q43587535 | Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China |
| Q35097379 | MiR-141 suppresses the migration and invasion of HCC cells by targeting Tiam1 |
| Q43183158 | MicroRNA-125b suppresses the migration and invasion of hepatocellular carcinoma cells by targeting transcriptional coactivator with PDZ-binding motif |
| Q37733274 | Optimized formulation of multivesicular liposomes loaded with oleanolic acid enhanced anticancer effect in vitro |
| Q64085546 | Outcomes of salvage liver transplant for recurrent hepatocellular carcinoma: A comparison with primary liver transplant |
| Q38464518 | Primary versus salvage living donor liver transplantation for patients with hepatocellular carcinoma: impact of microvascular invasion on survival |
| Q37687816 | Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection |
| Q42270431 | Prognostic value of preoperative peripheral neutrophil-to-lymphocyte ratio in patients with HBV-associated hepatocellular carcinoma after radical hepatectomy |
| Q40451238 | Prognostic value of preoperative serum gamma-glutamyltranspeptidase in patients with hepatocellular carcinoma after hepatectomy. |
| Q41124464 | Prospective validation of ab initio liver transplantation in hepatocellular carcinoma upon detection of risk factors for recurrence after resection. |
| Q41790928 | Radiofrequency ablation versus reresection in treating recurrent hepatocellular carcinoma: a meta-analysis. |
| Q82295922 | Recurrent hepatocellular carcinoma successfully treated with laparoscopic thermal ablation |
| Q91872489 | Repeat liver resection versus salvage liver transplant for recurrent hepatocellular carcinoma: A propensity score-adjusted and -matched comparison analysis |
| Q37848247 | Resection of a transplantable single-nodule hepatocellular carcinoma in Child-Pugh class A cirrhosis: factors affecting survival and recurrence. |
| Q48293892 | Salvage liver transplantation or repeat hepatectomy for recurrent hepatocellular carcinoma: An intent-to-treat analysis |
| Q53578154 | Surgical results for recurrent hepatocellular carcinoma after curative hepatectomy: Repeat hepatectomy versus salvage living donor liver transplantation. |
| Q42177882 | Survival advantage of primary liver transplantation for hepatocellular carcinoma within the up-to-7 criteria with microvascular invasion |
| Q38151787 | Systematic review of efficacy and outcomes of salvage liver transplantation after primary hepatic resection for hepatocellular carcinoma |
| Q64113089 | Systematic review of treatment strategy for recurrent hepatocellular carcinoma: Salvage liver transplantation or curative locoregional therapy |
| Q37995306 | Systematic review: the role of liver transplantation in the management of hepatocellular carcinoma |
| Q35106665 | The association of HMGB1 gene with the prognosis of HCC. |
| Q61799519 | The heterogeneity of plasma miRNA profiles in hepatocellular carcinoma patients and the exploration of diagnostic circulating miRNAs for hepatocellular carcinoma |
| Q87056300 | The postresection alpha-fetoprotein in cirrhotic patients with hepatocellular carcinoma. An independent predictor of outcome |
| Q35177271 | The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma |
| Q89513786 | The prognostic value of neuromedin U in patients with hepatocellular carcinoma |
| Q41194963 | The role of liver transplantation or resection for patients with early hepatocellular carcinoma |
| Q46497661 | Transplantation for hepatocellular carcinoma in younger patients has an equivocal survival advantage as compared with resection |
Search more.